Centrum 7/6  banner

Cardinal Health completes sale of Cordis business to Hellman & Friedman

Print Friendly, PDF & Email

DUBLIN, Ohio —  Cardinal Health  and Hellman & Friedman (H&F) announced Monday the completion of the previously announced sale of Cardinal Health’s Cordis business to H&F. The sale price of approximately $1 billion includes the buyer’s assumption of certain liabilities and the seller’s retention of certain working capital accounts.

“We appreciate H&F’s partnership throughout the transaction, and we are excited about Cordis’s future under H&F’s ownership,” said Mike Kaufmann, CEO of Cardinal Health. “As we shared previously, this divestiture demonstrates our disciplined portfolio evaluation approach, and we remain committed to investing in our strategic growth areas.”

“We are thrilled to begin this next chapter for Cordis and value the partnership with Cardinal Health through the transition,” said Shar Matin, CEO of Cordis. “We believe that an independent Cordis company, combined with an innovative approach to bring differentiated products to market, will allow us to create incremental value for teammates, customers and investors.”


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21